BPA Call W81K0020A0014-W81K0022F0168
Award Date 10/1/22
Potential Completion Date 9/30/23
Potential Value $25K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Bliss, TX 79918, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical manufacturer. The $17,447 contract is for the delivery of molecular imaging products for nuclear medicine, specifically Pharmalucence's SC05 Sulfur Colloid radiopharmaceutical kits. The contract has no set-aside designation, indicating open competition. Pharmalucence, Inc. is a for-profit, Subchapter S Corporation...
- This is a firm fixed price purchase order contract awarded by the Department of Defense Medical Command (MEDCOM) to Pharmalucence, Inc., a specialty pharmaceutical company, for the delivery of sulfur colloid kits. The contract has a ceiling value of $90,265.00 and a period of performance ending on September 30, 2016. Pharmalucence, Inc. has been awarded multiple federal contracts by the Department of Defense and its Defense Health Agency (DHA) component to supply radiopharmaceuticals and related...
- The Defense Health Agency awarded a $77,206.25 purchase order to Lantheus Medical Imaging, Inc. for radiopharmaceuticals on October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract, which carries no small business set-aside designation, supports medical imaging operations at Fort Bliss, Texas. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc. and based in North Billerica, Massachusetts, is a specialized manufacturer of diagnostic nuclear...
- This federal contract award is for the provision of various radiopharmaceuticals to the Defense Health Agency (DHA) and U.S. Army Medical Command. The prime contractor is Curium US LLC, a foreign-owned, for-profit manufacturer of nuclear medicine products. The contract was awarded on October 1, 2023 as a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type and a total ceiling value of $100,000.00. It has an ultimate completion date of September 30, 2024. The contract...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Petnet Solutions, Inc. for radiopharmaceuticals and supplies, with a ceiling value of $215,747.85 and a firm fixed-price structure. The contract, awarded on October 1, 2024, carries an ultimate completion date of September 30, 2025, and will be performed at Fort Bliss, Texas. This award was made without a set-aside designation, reflecting Petnet Solutions' competitive standing in the specialized radiopharmaceutical...
- The U.S. Defense Health Agency awarded a $21,834 firm-fixed-price Blanket Purchase Agreement (BPA) call to Sun Pharmaceutical Industries, Inc. for the supply of radiopharmaceuticals for nuclear medicine. The contract, which has no set-aside designation, will run through September 30, 2025. Sun Pharmaceutical, a for-profit manufacturer, has received previous prime contract awards from the Defense Health Agency for nuclear medicine imaging products, radiopharmaceutical delivery services, and...
- This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Pharmalucence, Inc., a for-profit manufacturer of pharmaceutical goods and medical supplies, for the delivery of radiopharmaceutical supplies, specifically sulfur colloid. The contract has a potential value of $162,030 and a period of performance ending on September 30, 2018. This award does not have a set-aside designation. Pharmalucence is an international, integrated, specialty pharmaceutical...
- The Defense Health Agency awarded a firm fixed-price purchase order to Bhpe LLC, a Native American-owned small business based in Oklahoma City, Oklahoma, for radiopharmaceuticals and cold kits to support William Beaumont Army Medical Center (WBAMC) at Fort Bliss, Texas. The contract, valued at $95,200 with no set-aside designation, was awarded on October 1, 2025, and extends through September 30, 2026. Radiopharmaceuticals are radioactive drugs used for diagnostic imaging and therapeutic...
- The Defense Health Agency awarded a $246,103.48 firm fixed-price purchase order to Petnet Solutions, Inc. for the supply of various radiopharmaceuticals to support the Department of Radiology, Nuclear Medicine Service at William Beaumont Army Medical Center in Fort Bliss, Texas. The contract, which commenced on October 1, 2025, and concludes on September 30, 2026, was awarded without a set-aside designation, reflecting open competition. Petnet Solutions, a Siemens subsidiary headquartered in...
- This federal contract award to Curium US LLC, a foreign-owned for-profit manufacturer of radiopharmaceuticals and nuclear medicine products, is a Blanket Purchase Agreement (BPA) call with a value of $249,999.96. The contract is with the Defense Health Agency (DHA) to provide radiopharmaceuticals, supplies, and related services to support healthcare operations at military medical facilities. The BPA allows DHA to issue firm fixed price call orders for Curium to deliver products such as...